Skip to main content
. 2019 Feb 19;133(16):1753–1761. doi: 10.1182/blood-2019-01-893339

Figure 3.

Figure 3.

Cancer-specific survival in primary effusion lymphoma. (A) Cancer-specific survival in entire cohort, (B) according to tumor EBER status, (C) according to serum IL-6 above or below the median, and (D) according to serum IL-10 above or below the median. P values from 2-sided log-rank test. med, median.